Package 0115-2134-01

Brand: pyridostigmine bromide

Generic: pyridostigmine bromide
NDC Package

Package Facts

Identity

Package NDC 0115-2134-01
Digits Only 0115213401
Product NDC 0115-2134
Product ID 0115-2134_83d6b85c-0cd0-467c-90aa-6998f5302559
Description

21 TABLET in 1 BOTTLE (0115-2134-01)

Marketing

Marketing Status
Marketed Since 2022-08-08
Brand pyridostigmine bromide
Generic pyridostigmine bromide
Sample Package No

Linked Drug Pages (1)

Pyridostigmine Bromide ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "83d6b85c-0cd0-467c-90aa-6998f5302559", "openfda": {"upc": ["0301152134019"], "unii": ["KVI301NA53"], "rxcui": ["903841"], "spl_set_id": ["91ca7bcf-d2cc-4cb3-bfbe-c294fd707524"], "manufacturer_name": ["Amneal Pharmaceuticals of New York LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "21 TABLET in 1 BOTTLE (0115-2134-01)", "package_ndc": "0115-2134-01", "marketing_start_date": "20220808"}], "brand_name": "Pyridostigmine Bromide", "product_id": "0115-2134_83d6b85c-0cd0-467c-90aa-6998f5302559", "dosage_form": "TABLET", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "0115-2134", "generic_name": "PYRIDOSTIGMINE BROMIDE", "labeler_name": "Amneal Pharmaceuticals of New York LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pyridostigmine Bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "30 mg/1"}], "application_number": "ANDA040502", "marketing_category": "ANDA", "marketing_start_date": "20220808", "listing_expiration_date": "20261231"}